Calyxt announces new strategic direction to provide sustainable, plant-based synthetic biology solutions to expanded group of end markets and diversified base of customers

Roseville, minn., oct. 5, 2021 /prnewswire/ --  calyxt, inc.  (nasdaq: clxt), a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will focus the company on engineering synthetic biology solutions for a diversified base of customers across an expanded group of end markets including the nutraceutical, cosmeceutical, pharmaceutical, advanced materials, and chemical industries.
CLXT Ratings Summary
CLXT Quant Ranking